An early phase II study of etoposide (VP-16) in advanced gastric cancer. 1996

T Yamao, and Y Shimada, and A Ohtsu, and K Hosokawa, and K Shirao, and H Kondo, and H Fukuda, and D Saito, and S Yoshida
Department of Medical Oncology, National Cancer Center Hospital, Tokyo.

An early phase II study was conducted to evaluate the anti-tumor effects and toxicity of etoposide in patients with unresectable or relapsed advanced gastric cancer. From April 1991 to December 1992, 13 patients were enrolled into this study; one was subsequently considered ineligible. Before enrollment, all the patients had been treated with chemotherapy which did not include etoposide. Etoposide (100 mg/m2/day) was administered as an intravenous infusion over 120 min for five consecutive days and was repeated every four weeks. Seven patients received one course of this therapy and the remaining five received two. No patient showed a complete or a partial response. No change and progressive disease were observed in three and nine patients, respectively. The clinical toxicities (grade 3-4; WHO) of leukocytopenia, anemia and alopecia occurred in 50, 42, and 42% of the patients, respectively. We conclude that this dose of etoposide administered according to the present schedule is ineffective in previously treated patients with advanced gastric cancer.

UI MeSH Term Description Entries
D007262 Infusions, Intravenous The long-term (minutes to hours) administration of a fluid into the vein through venipuncture, either by letting the fluid flow by gravity or by pumping it. Drip Infusions,Intravenous Drip,Intravenous Infusions,Drip Infusion,Drip, Intravenous,Infusion, Drip,Infusion, Intravenous,Infusions, Drip,Intravenous Infusion
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002288 Adenocarcinoma, Mucinous An adenocarcinoma producing mucin in significant amounts. (From Dorland, 27th ed) Carcinoma, Colloid,Carcinoma, Mucinous,Adenocarcinomas, Mucinous,Carcinomas, Colloid,Carcinomas, Mucinous,Colloid Carcinoma,Colloid Carcinomas,Mucinous Adenocarcinoma,Mucinous Adenocarcinomas,Mucinous Carcinoma,Mucinous Carcinomas
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005047 Etoposide A semisynthetic derivative of PODOPHYLLOTOXIN that exhibits antitumor activity. Etoposide inhibits DNA synthesis by forming a complex with topoisomerase II and DNA. This complex induces breaks in double stranded DNA and prevents repair by topoisomerase II binding. Accumulated breaks in DNA prevent entry into the mitotic phase of cell division, and lead to cell death. Etoposide acts primarily in the G2 and S phases of the cell cycle. Demethyl Epipodophyllotoxin Ethylidine Glucoside,Celltop,Eposide,Eposin,Eto-GRY,Etomedac,Etopos,Etoposide Pierre Fabre,Etoposide Teva,Etoposide, (5S)-Isomer,Etoposide, (5a alpha)-Isomer,Etoposide, (5a alpha,9 alpha)-Isomer,Etoposide, alpha-D-Glucopyranosyl Isomer,Etoposido Ferrer Farma,Exitop,Lastet,NSC-141540,Onkoposid,Riboposid,Toposar,VP 16-213,VP-16,Vepesid,Vépéside-Sandoz,Eto GRY,Etoposide, alpha D Glucopyranosyl Isomer,NSC 141540,NSC141540,Teva, Etoposide,VP 16,VP 16 213,VP 16213,VP16,Vépéside Sandoz,alpha-D-Glucopyranosyl Isomer Etoposide
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000230 Adenocarcinoma A malignant epithelial tumor with a glandular organization. Adenocarcinoma, Basal Cell,Adenocarcinoma, Granular Cell,Adenocarcinoma, Oxyphilic,Adenocarcinoma, Tubular,Adenoma, Malignant,Carcinoma, Cribriform,Carcinoma, Granular Cell,Carcinoma, Tubular,Adenocarcinomas,Adenocarcinomas, Basal Cell,Adenocarcinomas, Granular Cell,Adenocarcinomas, Oxyphilic,Adenocarcinomas, Tubular,Adenomas, Malignant,Basal Cell Adenocarcinoma,Basal Cell Adenocarcinomas,Carcinomas, Cribriform,Carcinomas, Granular Cell,Carcinomas, Tubular,Cribriform Carcinoma,Cribriform Carcinomas,Granular Cell Adenocarcinoma,Granular Cell Adenocarcinomas,Granular Cell Carcinoma,Granular Cell Carcinomas,Malignant Adenoma,Malignant Adenomas,Oxyphilic Adenocarcinoma,Oxyphilic Adenocarcinomas,Tubular Adenocarcinoma,Tubular Adenocarcinomas,Tubular Carcinoma,Tubular Carcinomas

Related Publications

T Yamao, and Y Shimada, and A Ohtsu, and K Hosokawa, and K Shirao, and H Kondo, and H Fukuda, and D Saito, and S Yoshida
October 1985, American journal of clinical oncology,
T Yamao, and Y Shimada, and A Ohtsu, and K Hosokawa, and K Shirao, and H Kondo, and H Fukuda, and D Saito, and S Yoshida
April 1981, Onkologie,
T Yamao, and Y Shimada, and A Ohtsu, and K Hosokawa, and K Shirao, and H Kondo, and H Fukuda, and D Saito, and S Yoshida
January 2005, Journal of B.U.ON. : official journal of the Balkan Union of Oncology,
T Yamao, and Y Shimada, and A Ohtsu, and K Hosokawa, and K Shirao, and H Kondo, and H Fukuda, and D Saito, and S Yoshida
September 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
T Yamao, and Y Shimada, and A Ohtsu, and K Hosokawa, and K Shirao, and H Kondo, and H Fukuda, and D Saito, and S Yoshida
March 1990, Gynecologic oncology,
T Yamao, and Y Shimada, and A Ohtsu, and K Hosokawa, and K Shirao, and H Kondo, and H Fukuda, and D Saito, and S Yoshida
January 1984, Cancer chemotherapy and pharmacology,
T Yamao, and Y Shimada, and A Ohtsu, and K Hosokawa, and K Shirao, and H Kondo, and H Fukuda, and D Saito, and S Yoshida
May 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
T Yamao, and Y Shimada, and A Ohtsu, and K Hosokawa, and K Shirao, and H Kondo, and H Fukuda, and D Saito, and S Yoshida
October 1985, Tumori,
T Yamao, and Y Shimada, and A Ohtsu, and K Hosokawa, and K Shirao, and H Kondo, and H Fukuda, and D Saito, and S Yoshida
January 1986, Gan to kagaku ryoho. Cancer & chemotherapy,
T Yamao, and Y Shimada, and A Ohtsu, and K Hosokawa, and K Shirao, and H Kondo, and H Fukuda, and D Saito, and S Yoshida
January 1982, Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg,
Copied contents to your clipboard!